Novogen Limited (NVGN) - NASDAQ
Company Description
Novogen Ltd. engages in the business of pharmaceutical drug development. The company's inaugural drug candidate CS-6 belongs to a new class of drug candidates known as Mitochondrial Electron Transfer Inhibitors that work by depriving the cancer cell of its main energy source. CS-6 is being... More
Sector: Healthcare
Industry: Drug Manufacturers - Major
Country: Australia